percentuali dell'area ROS+ calcolata rispettivamente negli SHR/veicolo e negl

SHR/GRA.

Conclusioni generali

Gli studi effettuati con questo lavoro di ricerca hanno dimostrato che la

somministrazione orale di 10mg/Kg/die di glucorafanina non porta a significativi

effetti protettivi cardiovascolari, salvo forse una modesta (e non statisticamente

significativa) azione antiossidante. Tale inefficacia potrebbe riflettere un

insufficente conversione del glucosinolato in isotiocianato.

Studi futuri saranno destinati a valutare effetti di dosaggi più elevati del

Bibliografia

 Amagasc H, Clarifying the real bioactive constituent of garlic. J.Nutr. 2006.136, 716-725.

 Banerjee S.K, Maulik S.K. Effects of Garlic on cardiovascular disorder. Nutr. J, 2002. 1,4.

 Benavides GA, Squadrito GL,Mills RW, Patel HD, Isbell TS, Patel RP, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci, USA 2007. 104, 17977-82.

 Brabban AD and Edward C (1994) Isolation of glucosinolate degrading microorganisms and their potential for reducing the glucosinolate content of rapemeal. FEMS Microbiol Lett 119, 83-88.

 C.C. Conaway, S.M. Gethanun, L.L. Liebes, D.J. Pusatieri. Nutr. Cancer, 2000,38, 168-178.

 Caliendo J, Cirino J, Santagada V, Wallace J.L. Synthesis and biological effects of hydrogen sulphide: development of H2S releasing drugs as a

pharmaceuticals. J. Chem. Med.2006 DOI: 10, 1021/jm901638j

 Cavallini D., Modovi B., Demarco C., Sciosciasantoro A. Inhibitory effect of mercaptoethanol and hypotaurine on the desulfhydration of cysteine by cystathionase. Arch. Biochem. Biophys., 1962. 96, 456-457.

 Chandy KG, Gutman GA. Voltage-gated potassium channels gene. Handbook of receptors and channels: Ligand and voltage-gated Ion channel (1995). 1, 1-71 .

 Chang L., Geng B., Yu F., Zhao J., Jian H, Du J, Thang C. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Aminoacids, 2008. 34, 573-585.

 Cheng DL, Hashimoto K. and Uda Y (2004). In vitro digestion of sinigrin and glucotropaeolin by single strains of Bifidobacterium and identification of the digestive products. Food Chem Toxicol 42, 351-357.

 Diwakar L, Ravindranath V. Inhibition of cystathionine-gammalyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS. Neurochem. Int. 2007.

 Elfoul L, Rabot S, Khelifa N, et al (2001) Formation of allyl isothiocyanate from sinigrin in the digestive tract of rats monoassociated whit a human colonic strain of Bacteroides thetaiotaomicron. Fems Microbiol Lett 197, 99-103.

 Fahey J.W. et al, 1997. Broccoli Sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Procl. Natl.Acad. Sci. USA 94, 10367-10372.

 Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C. Endogenous hydrogen sulphide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun, 2004. 313, 362-368., 756- 763.

 Goubern M, Andriamihaja M, Nubel T, Blachier F, Bouilaud F. Sulphide, the first inorganic substrate for human cells. Faseb J, 2007. 21, 1699-1706.

 Hildebrandt TM, Grieshaber MK. Three enzymatic activities catalyze the oxidation of sulphide to thiosulfate in mammalian and invertebrate mitochondria. Febs J, 2008. 275, 3352-3361.

 Jang H, Yang J, Qi Y, Zhao J, Pang Y, Du J, Thang C. H2S generated by heart in rat ad its effects on cardiac function. Biochem. Biophys. Res. Commun, 2004.

 K. Kassahun, M. Davis, P. Hu, B. Martin and T. Baille. Chem. Res. Toxicol., 1997, 10, 1228-1233.

 Kenneth R. Olson, Ryan A. Dombkowski, Michael J. Russell, Meredith M. Doellman, Sally K. Head, Nathan L. Whitfield and Jane A. Madden. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. The Journal of Experimental Biology.

 Koroleva O.A., et al, 2010. Glucosinolates accumulating S-cells in Arabidopsis leaves and flower stalks undergo programmed cell death at early stages of differentiation. Plant J. 64, 456-459.

 Lassila, M.; Davis, B. J.; Allen, T. J.; Burrel, L. M.; Cooper, M. E.;Cao, Z. Cardiovascular hypertrophy in diabetic spontaneously hypertensiverats: optimizing blockade of the renin-angiotensin system. Clin. Sci. 2003, 104, 341-347.

 Li L., Whiteman M., Guan Y.Y., Neo K.L., Cheng Y., Lee S.W, Zhao Y., Baskac R. Characterization of a novel, water soluble hydrogen sulphide- releasing molecul (GYY4137): new inshights into the bhiology of hydrogen sulphide. Circulation, 2008. 117, 2351-2360.

 Li Y.F, Xiao C.S, Hui RT. Calcium sulphide,a donor of hidrogen sulphide: a new anthypertensive drugs? Med.Hypoth., 2009. 73, 445-447.

 Llanos Palop M, Smiths JP and Brink BT (1995) Degradation of sinigrin by Lactobacillus agilis strain R16 Int J Food Micobiol 26,219-229.

 Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, Calderone V. Hydrogen sulfide: novel opportunity for drug discovery. Med Res Rev 2012. 32, 1093-1130.

 Martelli A, Testai L, Breschi MC, Lawson K, McKay NG, Miceli F, et al. vasorelaxation by hydrogen sulphide involves activation of K(v)7 potassium channels. Pharmacol Res 2013.

 Martelli A, Testai L, Breschi MC, Lawson K, McKay NG, Miceli F, Taglialatela M, Calderone V. Vasorelaxation by hydrogen sulphide involves activation of K(v)7 potassium channels. Pharmacol. Res. 2013. 70(1), 27-34.

 Martelli A, Testai L, Citi V, Marino A, Bellagambi FG, Ghimenti S, Breschi MC, Calderone V. Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? Vascul Pharmacol 2014. 60, 32-41.

 Martelli A, Testai L, Citi V, Marino A, Pugliesi I, Barresi E, et al. Arylthioamides as H2S donors: L-cysteine-activated releasing properties and vascular effects in vitro and in vivo. ACS Med Chem Lett 2013. 4, 904- 908.

 Martelli A, Testai L, Marino A, Breschi MC, Da Settimo F, Calderone V. Hydrogen sulfide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives. Curr Med Chem 2012. 19, 3325-3336.

 Martelli A, Testai L, Anzini M, Cappelli A, Di Capua A, Biava M, Poce G, Consalvi S, Giordani A, Caselli G, Rovati L, Ghelardini C, Patrignani C, Sautebin L, Breschi M.C, Calderone V. The novel anti-inflammatory agent VA694, endowed with bothNO-releasing and COX2-selective inhibiting properties, exhibitsNO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction Pharmacological Research 2013. 78, 1– 9.

 Mishra P.K, Tyagi N, Sen U, Givvimani S, Tyagi S.C. H2S ameliorates

oxidative and proteolytic stresses and protects the heart against adverse remodelling in chronic heart failure. Am.J. Physiol. Heart Circ. Physiol, 2010. 298, 451-456.

 Mukerjee et al, 2008. Broccoli: a unique vegetables that protects mammalian hearts Throught the redox cycling ok thioredoxine superfamily. J.Agric. Food Chem. 56, 609-617.

 P. K. Mishra, N. Tyagi, U. Sen, S. Givvimani, and S. C.Tyagi, “H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure,” American Journal of

Physiology—Heart and Circulatory Physiology, vol. 298, no. 2, pp. H451–

H456, 2010.

 Perna AF, Lanza D, Sepe I, Raiola I, Capasso R, De Santo NG, Ingrosso D. Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it? Blood Purif. 2011.

 Porter P, Grishaver M.S., Jones O.W. Characterization of human cystathionine beta-synathase: evidence for the identity of human L-serine dehydratase and cystathionine beta-synthase. Biochim. Bioghaphy. Acta, 1974. 364, 128-139.

 R. M. Osipov, M. P. Robich, J. Feng et al., “Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion:comparison of different administration regimens and characterizationof the cellular mechanisms of protection,” Journal of Cardiovascular Pharmacology, vol. 54, no. 4, pp. 287–297, 2009.

 R. Munday and C.M. Munday. J. Agric. Food Chem, 2004, 52, 1867-1871.

 R.H. Lai, A.S. Check, M. A. Walling, L.G. West. Food Chem, Toxicol., 2008, 46, 195-202.

 R.M. Bheemreddy and E.H. Jeffery, J. Agric. Food Chem. 2007, 55, 2861- 2866.

 Rabot S, Guercin C, Nougon-Boudon L, et al (1995) Glucosinolates degradation by bacteria strains isolated from a human intestinal microflora. Proc 9th Int Rapeseed Congress 1, 212-214.

 Robert K, Vialard F, Thiery E, Toyama K, Sinet PM, Janel N, London J. Expression of the cystathionine beta synthase (CBS) gene during mouse

development and immunolocalization in adult brain. J. Histochem. Cytochem. 2003.

 Rouzard G, Young SA and Duncan AJ, (2004). Hidrolysis of glucosinolates to isothiocyanates after ingestion of row or microwaved cabbage by human volunteers. Cancer Epidemiol Biomarkers. Prev 13, 125-131.

 Scavo P., Calderone V., Testai L. Solfuro di idrogeno e cardioprotezione: effetti di un H2S- donor di nuova generazione in un modello sperimentale

di ischemia-riperfusione. 2013, 36.

 Senanayake G.W. et al, 2012. The dietary phase 2 proteins inducer sulforaphane can normalyze the kidney epigenome and improved blood pressure in hipertensiv rats. Am. J. Hipertens. 25, 229-235.

 Shapiro T.A., et al, 1998. Human metabolism and excretion of cancer chemoprotective glucosinolate and isothyocianate of cruciferous vegetables. Cancer epidemiol. Biomarkers Prev. 7, 1091-1100.

 Shapyro TA, Fahey JW, Wade KL, et al (2001). Chemoprotective glucosinolate and isothiocyanates of broccoli sprouts: metabolism and excretion in human. Cancer Epidemiol Biomarkers Prev 10, 501-508.

 Stipanuk M.H., Beck P.W., Characterization of the enzimic capacity fot Cysteine desulphydratinon in liver and kidney of the rat. Biochem J. 1982. 206, 267-277.

 Tian XY,WongWT, Sayed N, Luo J, Tsang SY, Bian ZX, et al. NaHS relaxes rat cerebral artery in vitro via inhibition of l-type voltage-sensitive Ca2+

channel. Pharmacol Res 2012. 65, 239-46.

 W L. et al, 2004. Dietary approach to attenuate oxidative stress, hypertensions and inflammation in the cardiovascular system. Procl.Natl. Acad. Sci. USA. 101, 7094-7099.

 Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 2002.

 Whiteman M., Armstrong J.S. Chu S.H., Siau J-L, Cheung N.S, Halliwell B, Moore P.K. The novel neuromodulator hidrogen sulfide: an endogenous peroxynitrite “scavenger”. J.Neurochem 2004. 90. 765-768

 Xianglan Zhang, Xiao-Ou Shu, Yong-Bing Xiang, Gong Yang, Honglan Li, Jing Gao, Hui Cai, Yu-Tang Gao, and Wei Zheng. Cruciferous vegetable

consumption is associated with a reduced risk of total and cardiovascular disease mortality1–4.Am J Clin Nutr 2011;94:240–6.

 Y. Z. Zhu, J. W. Zhong, P. Ho et al., “Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats,” Journal of Applied

Physiology, vol. 102, no. 1, pp. 261–268, 2007. C. Indolfi, E. di Lorenzo, C.

Perrino et al., “Hydroxymethylglutaryl coenzyme a reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibitsp21ras activation,” Circulation, vol. 106, no. 16, pp. 2118– 2124,2002.

 Y.X. Shi, Y. Chen, Y.Z. Zhu, G.Y. Huang, P.K. Moore, S.H. Huang, et al., Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats, Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2093–H2100.

 Yaqi Shen, Zhuqing Shen, Shanshan Luo, Wei Guo and Yi Zhun Zhu. The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential. 2014.

 Zhang Y., et al, 1992. A major iducer of anticancerogenic protective enzymes from broccoli: isolatio and elucidation of structur. Proc. Natl.Acad. Sci. USA 89, 2399-2403.

 Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel

endogenous gaseous K(ATP) channel opener. EMBO J. 2001. 20, 6008- 6016.

 Zhao Y, Wang H, Xian M. L-Cysteine activated hydrogen sulfide (H2S)